ALMOST $22 million will be handed out by the Australian Government to support cancer clinical trials over the next three years.
The funding, administered by Cancer Australia, will support 14 multi-site collaborative cancer clinical trials groups across the country.
The program is integral to ensure targeted and innovative research investment, particularly in areas of unmet and emerging need.
It will also focus on improving clinical trial design, enhancing equitable access to trials, and accelerating the translation of research into clinical practice, directly contributing to better outcomes for Australians affected by cancer.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Oct 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Oct 24
